Aptus Endosystems has received CE mark approval for its EndoStapling system, which allows surgeons to treat abdominal aortic aneurysms through a minimally invasive approach while still providing the control of an open repair.
The helical staple technology enables independent endograft fixation, and is designed to mimic the hand suturing performed during open surgical repair of abdominal aortic aneurysms.
The EndoStapling system provides physicians with a novel technology to repair endovascular grafts that exhibits migration or endoleaks (or are at risk of these complications which are commonly seen after endovascular aneurysm repair (EVAR)) where augmented radial fixation and/or sealing is required to regain or maintain effective aortic aneurysm exclusion.
The system also can be used during de novo EVAR procedures (at the time of initial endograft implantation) to enhance an endograft’s inherent fixation and sealing mechanisms.
Aptus Endosystems CEO Jeff Elkins said to date, physicians have had limited prophylactic and treatment options for graft migration and Type I endoleaks.
"The novel concept of independent and physician controlled proximal fixation using the EndoStapling System is a considerable step toward addressing long term complications and making EVAR a more definitive solution for treating aortic aneurysms," Elkins said.
In addition to use with the Aptus endograft (which received CE mark approval in 2009), the Aptus EndoStapling system has received CE approval for use with the Cook Zenith, Gore Excluder, and Medtronic AneuRx, Endurant and Talent endografts in both initial implant and secondary repair settings.